Therapeutic Asset Ratings
1,027 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
rc48
Ovarian Carcinoma
Peking University Cancer Hospital & Institute
P2
CCC
(53)
rc48
Primary Peritoneal Carcinoma
Peking University Cancer Hospital & Institute
P2
CCC
(53)
rc48
RC48
Sun Yat-sen University
P2
CCC
(53)
rc48-adc
Adjuvant Chemotherapy
M.D. Anderson Cancer Center
P2
CCC
(53)
rc48-adc
Adjuvant Therapy
Zhejiang University
P2
CCC
(53)
rc48-adc
Gastric Cancer
Seagen, a wholly owned subsidiary of Pfizer
P2
CCC
(53)
rc48-adc
Anal Carcinoma
SOLTI Breast Cancer Research Group
P2
CCC
(53)
rc48-adc
B-NHL
Ruijin Hospital
P2
CCC
(53)
rc48-adc
Carcinoma of Unknown Primary
SOLTI Breast Cancer Research Group
P2
CCC
(53)
rc48-adc
CART Therapy
Ruijin Hospital
P2
CCC
(53)
rc48-adc
Castration-Resistant Prostate Carcinoma
RemeGen Co., Ltd.
P2
CCC
(53)
rc48-adc
Cervical Carcinoma
SOLTI Breast Cancer Research Group
P2
CCC
(53)
rc48-adc
Chemoembolization, Therapeutic
Sichuan Cancer Hospital and Research Institute
P2
CCC
(53)
rc48-adc
Concurrent Chemoradiotherapy
Sun Yat-sen University
P2
CCC
(53)
rc48-adc
Consolidation Immunotherapy
Peking University Cancer Hospital & Institute
P2
CCC
(53)
rc48-adc
Consolidation Therapy
Sun Yat-sen University
P2
CCC
(53)
rc48-adc
Conversion Therapy
Sichuan Cancer Hospital and Research Institute
P2
CCC
(53)
rc48-adc
ctDNA
M.D. Anderson Cancer Center
P2
CCC
(53)
rc48-adc
Disitamab Vedotin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
CCC
(53)
rc48-adc
ERBB2 Gene Duplication
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
CCC
(53)
rc48-adc
ERBB2 Mutation-Related Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
CCC
(53)
rc48-adc
Fruquintinib
M.D. Anderson Cancer Center
P2
CCC
(53)
rc48-adc
Fumarate Hydratase Deficient Renal Cell Carcinoma
RenJi Hospital
P2
CCC
(53)
rc48-adc
Glioblastoma Multiforme
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
P2
CCC
(53)
rc48-adc
Head And Neck Neoplasm
Seagen, a wholly owned subsidiary of Pfizer
P2
CCC
(53)
Showing 401 to 425 of 1,027 assets
Previous
Page 17 of 42
Next